These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10209498)

  • 1. Autoantibodies against C1q: view on clinical relevance and pathogenic role.
    Siegert CE; Kazatchkine MD; Sjöholm A; Würzner R; Loos M; Daha MR
    Clin Exp Immunol; 1999 Apr; 116(1):4-8. PubMed ID: 10209498
    [No Abstract]   [Full Text] [Related]  

  • 2. C1q as antigen in humoral autoimmune responses.
    Siegert CE; Daha MR
    Immunobiology; 1998 Aug; 199(2):295-302. PubMed ID: 9777413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of anti-C1q autoantibodies to lupus nephritis.
    Tsirogianni A; Pipi E; Soufleros K
    Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis.
    Trouw LA; Daha MR
    Expert Opin Biol Ther; 2005 Feb; 5(2):243-51. PubMed ID: 15757386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
    Chen PC; Wang CR; Liu MF; Chen FF; Liang CC
    Asian Pac J Allergy Immunol; 2002 Dec; 20(4):223-7. PubMed ID: 12744622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation.
    O'Flynn J; Flierman R; van der Pol P; Rops A; Satchell SC; Mathieson PW; van Kooten C; van der Vlag J; Berden JH; Daha MR
    Mol Immunol; 2011 Oct; 49(1-2):75-83. PubMed ID: 21855148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
    Potlukova E; Kralikova P
    Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis.
    Flierman R; Daha MR
    Mol Immunol; 2007 Jan; 44(1-3):133-8. PubMed ID: 16870257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis.
    Bigler C; Hopfer H; Danner D; Schaller M; Mihatsch MJ; Trendelenburg M
    Nephrol Dial Transplant; 2011 Apr; 26(4):1220-8. PubMed ID: 20841491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
    Pang Y; Yang XW; Song Y; Yu F; Zhao MH
    Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
    Dhir V
    Pol Arch Med Wewn; 2012; 122(3):123; author reply 123-4. PubMed ID: 22460042
    [No Abstract]   [Full Text] [Related]  

  • 12. Lupus nephritis sera contain autoantibodies that recognize epitopes within the globular fragment of C1q.
    Deliyska B; Tsacheva I; Radanova M; Stoianova V; Tchorbadjieva M; Dobreva N
    Med Pregl; 2007; 60 Suppl 2():25-7. PubMed ID: 18928152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Idiotype scFv Localizes an Autoepitope in the Globular Domain of C1q.
    Todorova N; Rangelov M; Bogoeva V; Stoyanova V; Yordanova A; Nikolova G; Georgiev H; Dimitrova D; Mohedin S; Stoyanova K; Tsacheva I
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-C1q autoantibodies in murine lupus nephritis.
    Trouw LA; Seelen MA; Visseren R; Duijs JM; Benediktsson H; de Heer E; Roos A; van Kooten C; Daha MR
    Clin Exp Immunol; 2004 Jan; 135(1):41-8. PubMed ID: 14678263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
    Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against C1q in patients with systemic lupus erythematosus.
    Trendelenburg M
    Springer Semin Immunopathol; 2005 Nov; 27(3):276-85. PubMed ID: 16189648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC; Zhou B; Dong Y
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
    Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-C1q Autoantibodies from Systemic Lupus Erythematosus Patients Induce a Proinflammatory Phenotype in Macrophages.
    Thanei S; Trendelenburg M
    J Immunol; 2016 Mar; 196(5):2063-74. PubMed ID: 26829984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare.
    Birmingham DJ; Bitter JE; Ndukwe EG; Dials S; Gullo TR; Conroy S; Nagaraja HN; Rovin BH; Hebert LA
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):47-53. PubMed ID: 26700439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.